Ignite Creation Date:
2025-12-25 @ 4:43 AM
Ignite Modification Date:
2026-01-26 @ 11:23 PM
Study NCT ID:
NCT01063218
Status:
COMPLETED
Last Update Posted:
2012-03-12
First Post:
2010-02-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application
Sponsor:
Galderma Brasil Ltda.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BR.09.001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mario Cézar Pires
Old Organization:
Complexo Hospitalar Padre Bento de Guarulhos